Abstract
Since platelet release reaction products (e.g. serotonin, ADP) stimulate prostacyclin (PGI2) release in vitrom, we have investigated whether thromboxane A2 (TXA2) also has a similar effect. An analogue, U-46619, was used for the experiments, since TXA2 is extremely unstable. U-46619 stimulated rat aortic PGI2 release; this stimulation was abolished by (a) EDTA and (b) verapamil. We conclude that TXA2 is a calcium-dependent stimulator of PGI2 release; this property may be relevant to the limitation of platelet aggregates in vivo and to vascular injury.
| Original language | English |
|---|---|
| Pages (from-to) | 259-262 |
| Number of pages | 4 |
| Journal | European Journal of Pharmacology |
| Volume | 107 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 2 1985 |
Keywords
- Prostacyclin
- Thromboxane A
- U-46619
- Verapamil
Fingerprint
Dive into the research topics of 'Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver